论文部分内容阅读
目的观察米索前列醇用于药物流产后子宫出血的临床效果。方法将300例自愿要求药物流产的早孕妇女给予常规服用米非司酮和米索前列醇片,并于排胎后5 d复查B超,提示宫内强回声光团者作随机分为观察组150例和对照组150例。观察组给予加服米索前列醇片600μg,1周后复查B超,对照组未做特殊处理,同样1周后复查。结果观察组加服米索前列醇后完全流产率为95.33%,明显优于对照组的84.67%(P<0.05)。结论米索前列醇用于药物流产后子宫出血,能有效提高药物流产的完全流产率,有效避免了因蜕膜组织残留而需行手术清宫,值得临床推广应用。
Objective To observe the clinical effect of misoprostol for uterine bleeding after medical abortion. Methods 300 pregnant women who volunteered for medical abortion were given mifepristone and misoprostol tablets routinely. The ultrasonography was performed on the 5th day after the birth of the fetus, which indicated that the intrauterine strong echo light groups were randomly divided into observation Group 150 cases and control group 150 cases. Observation group was given additional misoprostol tablets 600μg, 1 week after the review B ultrasound, the control group without special treatment, the same 1 week after the review. Results The abortion rate of the observation group after taking misoprostol was 95.33%, which was significantly better than that of the control group (84.67%, P <0.05). Conclusion Misoprostol for uterine bleeding after medical abortion, which can effectively improve the complete abortion rate of drug abortion, which effectively avoids the need for surgical curettage due to decidual tissue residue, which is worthy of clinical application.